In the Aβ1–42-induced mouse model of Alzheimer’s disease (AD), oridonin sharply rescues synaptic loss induced by Aβ1–42, lessens the alterations in dendritic structure and spine density, augment PSD-95 and promotes mitochondrial activity (Wang J. et al., 2016). The gene discussed is DLG4; the disease is Alzheimer disease.